Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab : subanalysis of the SA
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-12-01
著者
-
NISHIMOTO Norihiro
Laboratory of Immune Regulation, Wakayama Medical University
-
Nishimoto Norihiro
Laboratory Of Immune Regulation Graduate School Of Frontier Biosciences Osaka University
-
Nishimoto Norihiro
Laboratory Of Immune Regulation Wakayama Medical University
-
Takagi Nobuhiro
Chugai Pharmaceutical Co. Ltd.
-
Nishimoto Norihiro
Laboratory Of Immune Regulation
関連論文
- A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs
- Characteristics of fracture and related factors in patients with rheumatoid arthritis
- Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) : significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition
- Humanized Anti-Interleukin 6 Receptor Antibody Induced Long-term Remission in a Patient with Life-Threatening Refractory Autoimmune Hemolytic Anemia
- Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment : a report of two cases
- A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab
- A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years
- Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab : subanalysis of the SA
- Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
- Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
- Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab : a report of two cases
- Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases
- Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis : the JMAAV study
- Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents : a retrospective multicenter study in Japan